Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

NCT03293173 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

COMBINATION_PRODUCT: R-CHOEP
COMBINATION_PRODUCT: DA-EPOCH-R

Sponsor

Nordic Lymphoma Group

Collaborators

[object Object]
[object Object]